ROGSX
Price
$66.35
Change
+$0.38 (+0.58%)
Updated
Jun 2 closing price
Net Assets
847.54M
SLMCX
Price
$248.61
Change
+$8.80 (+3.67%)
Updated
Jun 2 closing price
Net Assets
28.72B
Interact to see
Advertisement

ROGSX vs SLMCX

Header iconROGSX vs SLMCX Comparison
Open Charts ROGSX vs SLMCXBanner chart's image
ROGSX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
ROGSX vs. SLMCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROGSX is a Buy and SLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 28.7B vs. ROGSX (848M). ROGSX pays higher dividends than SLMCX: ROGSX (0.03) vs SLMCX (0.00). ROGSX was incepted earlier than SLMCX: ROGSX (27 years) vs SLMCX (43 years). SLMCX (1.16) is less costly to investors than ROGSX (0.90). SLMCX is a more actively managed with annual turnover of: 33.00 vs. ROGSX (4.00). ROGSX (2000) and SLMCX (2000) have matching initial minimum investment requirements. SLMCX annual gain was more profitable for investors over the last year : 103.94 vs. ROGSX (39.46). SLMCX return over 5 years is better than : 97.78 vs. ROGSX (62.90).
ROGSXSLMCXROGSX / SLMCX
Total Expense Ratio0.901.1678%
Annual Report Gross Expense Ratio0.901.1678%
Fund Existence27 years43 years-
Gain YTD20.69253.03839%
Front LoadN/A6%-
Min. Initial Investment20002000100%
Min. Initial Investment IRAN/AN/A-
Net Assets848M28.7B3%
Annual Yield % from dividends0.030.00-
Returns for 1 year39.46103.9438%
Returns for 3 years89.09137.0165%
Returns for 5 years62.9097.7864%
Returns for 10 years291.16327.6289%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DILCX16.280.26
+1.62%
Davis International C
CSFCX57.30N/A
N/A
Cohen & Steers Global Realty C
OGLYX96.57N/A
N/A
Invesco Global Y
MXETX14.47N/A
N/A
Empower Core Strategies US Eq Inv
LYFCX15.83N/A
N/A
AlphaCentric Life Sciences & Hlthcare C